EquityZen Growth Technology Fund II LLC - Series 23
Raised
$3M
Investors
6
Min Invest
$249,999
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund II LLC - Series 23 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett on July 25, 2025. The vehicle raised $3.2M from 6 investors under Rule 506(b) and 3(c) exemptions with a $250K minimum investment. This is part of the EquityZen platform, which has 150 related EDGAR entities focused on private equity secondary transactions.
This offering represents a typical SPV structure within the private equity secondary market, using the standard 506(b) exemption for accredited investors with a mid-tier $250K minimum investment. The $533K average check size and small investor count are consistent with single-company exposure vehicles common to secondary marketplace platforms.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
